Cargando…
Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study
BACKGROUND: Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxi...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437065/ https://www.ncbi.nlm.nih.gov/pubmed/33852722 http://dx.doi.org/10.1093/ageing/afab059 |
_version_ | 1783752100963942400 |
---|---|
author | Gould, Rebecca L Wetherell, Julie Loebach Kimona, Kate Serfaty, Marc A Jones, Rebecca Graham, Christopher D Lawrence, Vanessa Livingston, Gill Wilkinson, Philip Walters, Kate Le Novere, Marie Leroi, Iracema Barber, Robert Lee, Ellen Cook, Jo Wuthrich, Viviana M Howard, Robert J |
author_facet | Gould, Rebecca L Wetherell, Julie Loebach Kimona, Kate Serfaty, Marc A Jones, Rebecca Graham, Christopher D Lawrence, Vanessa Livingston, Gill Wilkinson, Philip Walters, Kate Le Novere, Marie Leroi, Iracema Barber, Robert Lee, Ellen Cook, Jo Wuthrich, Viviana M Howard, Robert J |
author_sort | Gould, Rebecca L |
collection | PubMed |
description | BACKGROUND: Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxiety disorder (TR-GAD) in older people. OBJECTIVES: To examine the acceptability, feasibility and preliminary estimates of the effectiveness of acceptance and commitment therapy (ACT) for older people with TR-GAD. PARTICIPANTS: People aged ≥65 years with TR-GAD (defined as not responding to GAD treatment, tolerate it or refused treatment) recruited from primary and secondary care services and the community. INTERVENTION: Participants received up to 16 one-to-one sessions of ACT, developed specifically for older people with TR-GAD, in addition to usual care. MEASUREMENTS: Co-primary outcomes were feasibility (defined as recruitment of ≥32 participants and retention of ≥60% at follow-up) and acceptability (defined as participants attending ≥10 sessions and scoring ≥21/30 on the satisfaction with therapy subscale). Secondary outcomes included measures of anxiety, worry, depression and psychological flexibility (assessed at 0 and 20 weeks). RESULTS: Thirty-seven participants were recruited, 30 (81%) were retained and 26 (70%) attended ≥10 sessions. A total of 18/30 (60%) participants scored ≥21/30 on the satisfaction with therapy subscale. There was preliminary evidence suggesting that ACT may improve anxiety, depression and psychological flexibility. CONCLUSIONS: There was evidence of good feasibility and acceptability, although satisfaction with therapy scores suggested that further refinement of the intervention may be necessary. Results indicate that a larger-scale randomised controlled trial of ACT for TR-GAD is feasible and warranted. |
format | Online Article Text |
id | pubmed-8437065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-84370652021-09-14 Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study Gould, Rebecca L Wetherell, Julie Loebach Kimona, Kate Serfaty, Marc A Jones, Rebecca Graham, Christopher D Lawrence, Vanessa Livingston, Gill Wilkinson, Philip Walters, Kate Le Novere, Marie Leroi, Iracema Barber, Robert Lee, Ellen Cook, Jo Wuthrich, Viviana M Howard, Robert J Age Ageing Research Paper BACKGROUND: Generalised anxiety disorder (GAD) is the most common anxiety disorder in older people. First-line management includes pharmacological and psychological therapies, but many do not find these effective or acceptable. Little is known about how to manage treatment-resistant generalised anxiety disorder (TR-GAD) in older people. OBJECTIVES: To examine the acceptability, feasibility and preliminary estimates of the effectiveness of acceptance and commitment therapy (ACT) for older people with TR-GAD. PARTICIPANTS: People aged ≥65 years with TR-GAD (defined as not responding to GAD treatment, tolerate it or refused treatment) recruited from primary and secondary care services and the community. INTERVENTION: Participants received up to 16 one-to-one sessions of ACT, developed specifically for older people with TR-GAD, in addition to usual care. MEASUREMENTS: Co-primary outcomes were feasibility (defined as recruitment of ≥32 participants and retention of ≥60% at follow-up) and acceptability (defined as participants attending ≥10 sessions and scoring ≥21/30 on the satisfaction with therapy subscale). Secondary outcomes included measures of anxiety, worry, depression and psychological flexibility (assessed at 0 and 20 weeks). RESULTS: Thirty-seven participants were recruited, 30 (81%) were retained and 26 (70%) attended ≥10 sessions. A total of 18/30 (60%) participants scored ≥21/30 on the satisfaction with therapy subscale. There was preliminary evidence suggesting that ACT may improve anxiety, depression and psychological flexibility. CONCLUSIONS: There was evidence of good feasibility and acceptability, although satisfaction with therapy scores suggested that further refinement of the intervention may be necessary. Results indicate that a larger-scale randomised controlled trial of ACT for TR-GAD is feasible and warranted. Oxford University Press 2021-04-13 /pmc/articles/PMC8437065/ /pubmed/33852722 http://dx.doi.org/10.1093/ageing/afab059 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Research Paper Gould, Rebecca L Wetherell, Julie Loebach Kimona, Kate Serfaty, Marc A Jones, Rebecca Graham, Christopher D Lawrence, Vanessa Livingston, Gill Wilkinson, Philip Walters, Kate Le Novere, Marie Leroi, Iracema Barber, Robert Lee, Ellen Cook, Jo Wuthrich, Viviana M Howard, Robert J Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
title | Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
title_full | Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
title_fullStr | Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
title_full_unstemmed | Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
title_short | Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
title_sort | acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437065/ https://www.ncbi.nlm.nih.gov/pubmed/33852722 http://dx.doi.org/10.1093/ageing/afab059 |
work_keys_str_mv | AT gouldrebeccal acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT wetherelljulieloebach acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT kimonakate acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT serfatymarca acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT jonesrebecca acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT grahamchristopherd acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT lawrencevanessa acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT livingstongill acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT wilkinsonphilip acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT walterskate acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT lenoveremarie acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT leroiiracema acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT barberrobert acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT leeellen acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT cookjo acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT wuthrichvivianam acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy AT howardrobertj acceptanceandcommitmenttherapyforlatelifetreatmentresistantgeneralisedanxietydisorderafeasibilitystudy |